European Lithium 报告了来自格陵兰岛的强劲稀土结果，而 Moderna 则启动了其首次 mRNA 癌症试验。 European Lithium reports strong rare earth results from Greenland, while Moderna launches its first mRNA cancer trial.

欧洲锂有限公司报告说,该公司在格陵兰的Tanbreez稀土项目取得了强有力的分析结果,历史山地矿床样本平均占稀土氧化物总量的0.58%和重稀土的24.9%,超过了预期。 European Lithium Ltd reported strong assay results from its Tanbreez rare earths project in Greenland, with historic Hill deposit samples averaging 0.58% total rare earth oxides and 24.9% heavy rare earths, exceeding expectations. 该公司通过出售关键金属公司的股份、创造资本和继续降低其欧洲锂资产的风险,推进了其战略重点。 The company advanced its strategic focus by selling shares in Critical Metals Corp, generating capital, and continued de-risking its European lithium assets. 与此同时,Mmoda开始对MRNA-2808进行第1/2阶段试验,这是它第一次使用MRNA技术进行癌症免疫治疗,目标是复发的多重骨髓瘤。 Meanwhile, Moderna initiated a Phase 1/2 trial for mRNA-2808, its first cancer immunotherapy using mRNA technology, targeting relapsed multiple myeloma. Imugene的全方位CAR-T疗法Azer-cel在2025年ASH会议上得到了口头介绍,显示出治疗复发的大型B细胞淋巴瘤的早期前景。 Imugene’s allogeneic CAR-T therapy azer-cel received an oral presentation slot at the ASH 2025 meeting, showing early promise in treating relapsed large B-cell lymphoma. 在医疗保健方面,Genena Pty Ltd因数据被违反而面临代表申诉,这暴露了IVF病人的信息,引起了对隐私的担忧。 In healthcare, Genea Pty Ltd faces a representative complaint over a data breach exposing IVF patient information, raising privacy concerns. 在金融市场上,美国股票市场最终出现混合,在与AI相关的强劲势头下,技术股票领先于增长。 In financial markets, the U.S. stock market ended mixed, with tech stocks leading gains amid strong AI-related momentum.